Activation of the alternative and classical complement pathways by Entamoeba histolytica.

Por Calderon, J, Schreiber, R D
Publicado em 1985

Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection.

Por Buchmeier, N A, Schreiber, R D
Publicado em 1985

CD8 T cells can protect against an intracellular bacterium in an interferon gamma-independent fashion.

Por Harty, J T, Schreiber, R D, Bevan, M J
Publicado em 1992

Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.

Por Mayes, J T, Schreiber, R D, Cooper, N R
Publicado em 1984

Identification of a functionally important sequence in the C terminus of the interferon-gamma receptor.

Por Farrar, M A, Campbell, J D, Schreiber, R D
Publicado em 1992

Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli.

Por Wherry, J C, Schreiber, R D, Unanue, E R
Publicado em 1991

Antibody-independent activation of the alternative complement pathway by measles virus-infected cells.

Por Sissons, J G, Oldstone, M B, Schreiber, R D
Publicado em 1980

Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.

Por Pangburn, M K, Schreiber, R D, Müller-Eberhard, H J
Publicado em 1983

Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain.

Por Marsters, S A, Pennica, D, Bach, E, Schreiber, R D, Ashkenazi, A
Publicado em 1995

Transforming growth factor beta decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a mon...

Por Carel, J C, Schreiber, R D, Falqui, L, Lacy, P E
Publicado em 1990

IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes.

Por Thomas, H E, Parker, J L, Schreiber, R D, Kay, T W
Publicado em 1998

Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.

Por Murray, H W, Oca, M J, Granger, A M, Schreiber, R D
Publicado em 1989

A molecular concept of the properdin pathway.

Por Medicus, R G, Schreiber, R D, Götze, O, Müller-Eberhard, H J
Publicado em 1976

Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91).

Por Greenlund, A C, Farrar, M A, Viviano, B L, Schreiber, R D
Publicado em 1994

Demonstration and partial characterization of the interferon-gamma receptor on human mononuclear phagocytes.

Por Celada, A, Allen, R, Esparza, I, Gray, P W, Schreiber, R D
Publicado em 1985

Purification and characterization of the human interferon-gamma receptor from placenta.

Por Calderon, J, Sheehan, K C, Chance, C, Thomas, M L, Schreiber, R D
Publicado em 1988

Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.

Por Schreiber, R D, Pangburn, M K, Lesavre, P H, Müller-Eberhard, H J
Publicado em 1978

Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.

Por Pace, J L, Russell, S W, Schreiber, R D, Altman, A, Katz, D H
Publicado em 1983

Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.

Por Tausk, F A, McCutchan, A, Spechko, P, Schreiber, R D, Gigli, I
Publicado em 1986

Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma.

Por Bromberg, J F, Horvath, C M, Wen, Z, Schreiber, R D, Darnell, J E
Publicado em 1996